ADGM · Adagio Medical Holdings, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“We do not believe our existing cash and cash equivalents will be sufficient to fund operations for at least the next twelve months from the issuance date of the condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q. We believe that this raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $0 | $0 | — | $300K | |
| — | $684K | — | $1.31M | |
| — | -$684K | — | -$1.01M | |
| — | — | — | -335.33% | |
| $10.2M | $10.64M | — | $15.4M | |
| $9.62M | $10.57M | — | $11.54M | |
| — | $0 | — | — | |
| — | $970K | — | $532K | |
| $19.91M | $21.89M | — | $28.24M | |
| -$19.91M | -$21.89M | — | -$27.94M | |
| — | — | — | -9314% | |
| — | -$20.92M | — | -$27.41M | |
| $3.11M | $2.91M | — | $1.66M | |
| $390K | $477K | — | $3000 | |
| -$7.23M | -$3.19M | — | -$8.65M | |
| — | -$25.32M | — | -$36.59M | |
| — | $0 | $0 | $0 | |
| -$27.14M | -$25.08M | — | -$36.59M | |
| — | — | — | -12196.67% | |
| -$27.03M | -$25.18M | — | -$36.6M | |
| USD/shares | -$1.36 | -$1.51 | — | -$48.16 |
| USD/shares | -$1.26 | -$1.51 | — | -$48.16 |
| shares | — | 16.58M | — | 759.81K |
| shares | — | 16.58M | — | — |
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 66 similar-size Medical Devices companies (of 146 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2023 |
|---|---|
| Single Reportable Segment | $300,000 |